Get notified when TVTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TVTX Travere Therapeutics, Inc. 8-K

Travere shareholders approve 3M share equity plan increase, elect all ten directors

Filed May 21, 2026 · Period ending May 19, 2026 · ~1 min read

Key Changes

  • medium

    Shareholders approved adding 3,000,000 shares to the 2018 Equity Incentive Plan (79.0% of shares outstanding voting for), bringing total authorized shares to 25.4M and expanding the pool for employee equity compensation.

  • medium

    All ten director nominees elected to serve until 2027 annual meeting. Support ranged from 87.7% to 99.0% of votes cast; Dr. Roy Baynes received lowest support at 87.7% with 9.3M withheld votes (12.3% opposition).

  • low

    Say-on-pay vote passed with 97.3% support (79.8% of shares outstanding); shareholders indicated strong preference for annual say-on-pay votes (98.9% favoring one-year frequency).

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade TVTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify